Back to Authors

Piscopo, Jennifer

A5105065697 | I1340179700

Mayo Clinic

NewYork–Presbyterian Hospital

Citations 1

Combination of Radiation Therapy and Irreversible Electroporation for Intermediate-Risk Prostate Cancer (RTIRE): A Phase 1 Trial

Radiology | July 28, 2026 | Volume: 320 | Issue: 1 | Pages: No page available

10.1148/radiol.250848 | PMID 42517770

Treatment of participants with intermediate-risk prostate cancer with focal irreversible electroporation and radiation therapy was technically feasible and showed acceptable patient-reported outcomes and no severe adverse events over 1 year.